SUSMAN SALLY
Pfizer Inc's CEO offloaded 62% of his stock holdings post Covid-19 vaccine trial success announcementIn an SEC filing on late Tuesday, Bourla disclosed that he has sold 62 per cent of his stock holdings, or 1,32,508 shares, at $41.94 per sh...
Pfizer, Roche end association with US-India Business CouncilUS-based Pfizer and Switzerland's Roche end their association with USIBC
- Load More